Kar‐Ming Fung

2.1k total citations
39 papers, 1.6k citations indexed

About

Kar‐Ming Fung is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Kar‐Ming Fung has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 11 papers in Molecular Biology and 9 papers in Neurology. Recurrent topics in Kar‐Ming Fung's work include Glioma Diagnosis and Treatment (16 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Neurofibromatosis and Schwannoma Cases (5 papers). Kar‐Ming Fung is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Neurofibromatosis and Schwannoma Cases (5 papers). Kar‐Ming Fung collaborates with scholars based in United States, Vietnam and South Korea. Kar‐Ming Fung's co-authors include John Q. Trojanowski, V. M.-Y. Lee, Edmund Neugebauer, Andreas D. Rink, Tracy K. McIntosh, L. Sutton, Peter C. Phillips∥, Anna J. Janss, Cong Tang and B. Powell and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Kar‐Ming Fung

37 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kar‐Ming Fung United States 18 915 390 330 262 207 39 1.6k
Sung‐Hye Park South Korea 24 583 0.6× 382 1.0× 446 1.4× 172 0.7× 206 1.0× 112 1.7k
Tadahisa Shono Japan 21 956 1.0× 277 0.7× 293 0.9× 551 2.1× 391 1.9× 64 2.2k
Knut Dietzmann Germany 24 1.0k 1.1× 397 1.0× 379 1.1× 252 1.0× 339 1.6× 90 2.0k
Gillian M. Borthwick United Kingdom 19 1.1k 1.2× 287 0.7× 158 0.5× 205 0.8× 159 0.8× 28 1.8k
Laura Harrington United Kingdom 13 1.4k 1.5× 203 0.5× 98 0.3× 196 0.7× 237 1.1× 17 1.9k
Zhiyuan Zhu China 19 554 0.6× 171 0.4× 119 0.4× 340 1.3× 125 0.6× 46 1.2k
Esther Castaño Spain 20 856 0.9× 110 0.3× 147 0.4× 376 1.4× 401 1.9× 49 1.6k
Liliana Viera United States 17 647 0.7× 342 0.9× 190 0.6× 133 0.5× 71 0.3× 34 1.5k
Xiuli Jiang China 20 721 0.8× 167 0.4× 95 0.3× 372 1.4× 335 1.6× 50 1.4k

Countries citing papers authored by Kar‐Ming Fung

Since Specialization
Citations

This map shows the geographic impact of Kar‐Ming Fung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kar‐Ming Fung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kar‐Ming Fung more than expected).

Fields of papers citing papers by Kar‐Ming Fung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kar‐Ming Fung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kar‐Ming Fung. The network helps show where Kar‐Ming Fung may publish in the future.

Co-authorship network of co-authors of Kar‐Ming Fung

This figure shows the co-authorship network connecting the top 25 collaborators of Kar‐Ming Fung. A scholar is included among the top collaborators of Kar‐Ming Fung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kar‐Ming Fung. Kar‐Ming Fung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Battiste, James, et al.. (2024). Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example. World Neurosurgery. 185. e1093–e1100.
2.
Fung, Kar‐Ming, et al.. (2022). The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series. Frontiers in Oncology. 12. 846232–846232. 9 indexed citations
3.
Nofchissey, Robert A., Maaz Khan, Sheeja Aravindan, et al.. (2022). An analysis of sexual dimorphism in the tumor microenvironment of colorectal cancer. Frontiers in Oncology. 12. 986103–986103. 3 indexed citations
4.
Vuong, Huy Gia, Tam N.M. Ngo, Kar‐Ming Fung, et al.. (2021). H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients. Journal of Neuro-Oncology. 155(3). 225–234. 24 indexed citations
5.
Huang, Hsuan‐Ying, Chien‐Feng Li, Yung‐Ming Jeng, et al.. (2021). S100P as a marker for poor survival and advanced stage in gallbladder carcinoma. Annals of Diagnostic Pathology. 52. 151736–151736. 4 indexed citations
6.
Smith, Nataliya, Debra Saunders, Megan R. Lerner, et al.. (2021). ELTD1 as a multi-focal target for malignant gliomas: preclinical studies. Neuro-Oncology Advances. 3(1). vdab132–vdab132. 1 indexed citations
7.
Borczuk, Alain, Steven Salvatore, Kar‐Ming Fung, et al.. (2021). Tissue factor upregulation is associated with SARS‐CoV‐2 in the lungs of COVID‐19 patients. Journal of Thrombosis and Haemostasis. 19(9). 2268–2274. 37 indexed citations
8.
Vuong, Huy Gia, Thu Quynh Nguyen, Tam N.M. Ngo, et al.. (2020). The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis. BMC Cancer. 20(1). 897–897. 34 indexed citations
9.
Zhou, Zhijun, Guanggai Xia, Zhen Xiang, et al.. (2019). A C-X-C Chemokine Receptor Type 2–Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis. Clinical Cancer Research. 25(11). 3317–3328. 94 indexed citations
10.
Smith, Nataliya, Debra Saunders, Megan R. Lerner, et al.. (2019). Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment.. PubMed. 9(1). 93–109. 17 indexed citations
11.
Hannafon, Bethany N., et al.. (2019). miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study. BMC Cancer. 19(1). 642–642. 91 indexed citations
12.
Ha, Ji Hee, Rangasudhagar Radhakrishnan, Muralidharan Jayaraman, et al.. (2018). LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response. Cancer Research. 78(8). 1923–1934. 68 indexed citations
13.
Vuong, Huy Gia, Hanh Thi Tuyet Ngo, Thong Quang Pham, et al.. (2018). Prognostic significance of genetic biomarkers in isocitrate dehydrogenase‐wild‐type lower‐grade glioma: the need to further stratify this tumor entity – a meta‐analysis. European Journal of Neurology. 26(3). 379–387. 17 indexed citations
14.
Towner, Rheal A., Nataliya Smith, Debra Saunders, et al.. (2018). OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth. Translational Oncology. 12(2). 320–335. 43 indexed citations
15.
Krais, John J., et al.. (2017). Antitumor Synergism and Enhanced Survival with a Tumor Vasculature–Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide. Molecular Cancer Therapeutics. 16(9). 1855–1865. 10 indexed citations
16.
Ni, Xiao, Qing Yang, Kar‐Ming Fung, et al.. (2012). Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model. BMC Complementary and Alternative Medicine. 12(1). 253–253. 82 indexed citations
17.
18.
Fung, Kar‐Ming. (2001). Pathology of Skeletal Muscle (ed 2). Human Pathology. 32(11). 1277–1277. 1 indexed citations
19.
Peringa, Jan, Kar‐Ming Fung, Yoshihiro Muragaki, & John Q. Trojanowski. (1995). The cellular and molecular biology of medulloblastoma. Current Opinion in Neurology. 8(6). 437–440. 9 indexed citations
20.
Rink, Andreas D., Kar‐Ming Fung, John Q. Trojanowski, et al.. (1995). Evidence of apoptotic cell death after experimental traumatic brain injury in the rat.. PubMed. 147(6). 1575–83. 448 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung‐Hye Park Breakdown of academic impact, for papers by Tadahisa Shono Breakdown of academic impact, for papers by Knut Dietzmann Breakdown of academic impact, for papers by Gillian M. Borthwick Breakdown of academic impact, for papers by Laura Harrington Breakdown of academic impact, for papers by Zhiyuan Zhu Breakdown of academic impact, for papers by Esther Castaño Breakdown of academic impact, for papers by Liliana Viera Breakdown of academic impact, for papers by Xiuli Jiang
Rankless by CCL
2026